Aktie A1JUHH CELLULAR BIOMEDICINE GROUP, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Cellular Biomedicine Group, Inc.

Aktien

A1JUHH

US15117P1021

CBMG

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Nektar Therapeutics Announces New Clinical Study Collaboration with Cellular Biomedicine Group Inc. to Evaluate Nktr-255 in Combination with C-Til051 in Advanced Non-Small Cell Lung Cancer
Cellular Biomedicine Group Announces FDA Clearance of Investigational New Drug Application for Novel TIL Therapy C-TIL051
Cellular Biomedicine Group Inc Receives FDA Regenerative Medicine Advanced Therapy and Fast Track Designations for Bi-Specific Anti-CD19/CD20 CAR-T Cell Therapy for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Cellular Biomedicine Group Inc. Receives FDA Clearance of IND Application for Bi-Specific Anti-CD19/CD20 CAR-T Cell Therapy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Cellular Biomedicine Group, Inc. announced that it has received $120 million in funding from CICC Capital Management Co., Ltd., AstraZeneca PLC, Investment Arm, Yunfeng Capital, GIC Pte. Ltd., TF Capital, Sequoia China Investment Management LLP and other investors
Hillhouse Capital Provides Information to Shareholders of Hillhouse Capital
Cellular Biomedicine : Completes Merger with CBMG Holdings; Shares to No Longer Trade on Nasdaq
CELLULAR BIOMEDICINE GROUP, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
Cellular Biomedicine Group :, Inc. Announces Completion of Merger
Cellular Biomedicine Group, Inc.(NasdaqGS:CBMG) dropped from S&P Global BMI Index
Cellular Biomedicine Group, Inc.(NasdaqGS:CBMG) dropped from S&P TMI Index
Cellular Biomedicine Group, Inc.(NasdaqGS:CBMG) dropped from NASDAQ Composite Index
A consortium of buyers completed the acquisition of remaining 52.34% stake in Cellular Biomedicine Group, Inc. from a group of shareholders.
Cellular Biomedicine Group, Inc.(NasdaqGS:CBMG) dropped from Russell 2000 Defensive Index
Cellular Biomedicine Group, Inc.(NasdaqGS:CBMG) dropped from Russell 2000 Dynamic Index
Cellular Biomedicine Group, Inc.(NasdaqGS:CBMG) dropped from Russell 2000 Growth-Defensive Index
Cellular Biomedicine Group, Inc.(NasdaqGS:CBMG) dropped from Russell 2000 Value-Defensive Index
Cellular Biomedicine Group, Inc.(NasdaqGS:CBMG) dropped from Russell 2000 Index
Cellular Biomedicine Group, Inc.(NasdaqGS:CBMG) dropped from Russell 3000 Index
Cellular Biomedicine Group, Inc.(NasdaqGS:CBMG) dropped from Russell 2500 Index
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1JUHH Aktie
  4. Nachrichten Cellular Biomedicine Group, Inc.
  5. Andere Sprachen